MMS Holdings Inc is an award-winning clinical research organization (CRO) based in Canton, MI. With a strong focus on data and a scientific approach, MMS supports the pharmaceutical and biotech industries in navigating complex trial data and regulatory submission challenges. Their team of industry experts across four continents provides 24-hour support and has a 97 percent sponsor satisfaction rating.
With a proven track record of developing compelling submissions that meet rigorous regulatory standards, MMS is a valuable CRO partner. They offer a range of services including regulatory affairs, operations, data management, biostatistics, medical writing, drug safety, pharmacovigilance, quality compliance, and transparency services. MMS is dedicated to advancing innovation in mental health treatments and has supported the submission of the first psychedelic-assisted therapy for PTSD.
Generated from the website